RESEARCH PAPER
Clinical, sociodemographic and tobacco-use factors associated with smoking cessation rates at three years followup, Ankara, Turkey
Bilgen Esmer 1
,  
Funda Aksu 2
,  
Adem Özkara 1
,  
 
 
More details
Hide details
1
Ankara Numune Education and Research Hospital, Sıhhiye, Ankara, Turkey
2
Ankara Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Keçiören, Ankara, Turkey
CORRESPONDING AUTHOR
Kurtulus Aksu   

Department of Chest Diseases, Health Sciences University Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Keçiören, Ankara, Turkey
Publication date: 2019-12-02
Submission date: 2019-07-28
Final revision date: 2019-11-05
Acceptance date: 2019-11-07
 
Tob. Prev. Cessation 2019;5(December):47
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Smoking is a well-known major cause of early preventable mortality and morbidity. Maintenance of smoke-free status is important after a smoking cessation attempt. The present study aims to compare the sociodemographic and clinical characteristics of subjects participating in a smoking-cessation program, according to the duration of smoking cessation.

Methods:
A study was conducted in 261 smokers who had attended a smoking cessation clinic in a tertiary hospital, in Ankara, Turkey. The smoking status of the subjects at three years follow-up after participating in the smoking-cessation program was assessed. Sociodemographic, employment, environmental, smokingrelated, health and clinical characteristics of subjects were compared according to the smoking cessation duration.

Results:
Marital status, having a child, absence of household smoking and lower levels of nicotine dependence were significantly higher in quitters, and anxiety was lower. Parameters that significantly differed between subjects that were and were not abstinent for >36 months were marital status (p<0.001), childbearing status (p=0.007), household smoking (p<0.001), age of smoking initiation (p=0.02), psychiatric illness history (p=0.01), and number of follow-up visits (p<0.001). The number of follow-up visits at the smoking cessation clinic was an important factor of quitting and maintenance of quit status.

Conclusions:
Family and home environment as well as smoking-related and mental health characteristics influenced maintenance of long-term smoking cessation. Characteristics such as sociodemographic, clinical and smoking-related conditions should be considered in smoking cessation interventions. Personalized treatment strategies and follow-up visits at the smoking cessation clinic should be planned for maintenance of smoking cessation.

CONFLICTS OF INTEREST
The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
FUNDING
There was no source of funding for this research.
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer reviewed.
 
REFERENCES (22)
1.
World Health Organization. WHO Report on the Global Tobacco Epidemic: Enforcing bans on tobacco advertising, promotion and sponsorship. Geneva, Switzerland: World Health Organization; 2013. https://apps.who.int/iris/bits.... Accessed August 24, 2016.
 
2.
World Heath Organization. MPower: a policy package to reverse the tobacco epidemic. Geneva, Switzerland: World Health Organization; 2008. http://www.who.int/tobacco/mpo.... Accessed January 18, 2018.
 
3.
Calikoglu EO, Koycegiz E. Tobacco Control Policies in Turkey in Terms of MPOWER. Eurasian J Med. 2019;51(1):80-84. doi:10.5152/eurasianjmed.2018.18009
 
4.
Lando HA, McGovern PG, Barrios FX, Etringer BD. Comparative evaluation of American Cancer Society and American Lung Association smoking cessation clinics. Am J Public Health. 1990;80(5):554-559. doi:10.2105/ajph.80.5.554
 
5.
Renaud JM, Halpern MT. Clinical management of smoking cessation: patient factors affecting a reward-based approach. Patient Prefer Adherence. 2010;4:441-450. doi:10.2147/PPA.S8913
 
6.
Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146. doi:10.1002/14651858
 
7.
Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997 ;337(17):1195-1202. doi:10.1056/NEJM199710233371703
 
8.
Garrison GD, Dugan SE. Varenicline: a first-line treatment option for smoking cessation. Clin Ther. 2009;31(3):463-491. doi:10.1016/j.clinthera.2009.03.021
 
9.
Lee CW, Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health. 2007;97(8):1503-1509. doi:10.2105/AJPH.2005.083527
 
10.
Çelik İ, Yüce D, Hayran M, et al. Nationwide Smoking Cessation Treatment Support Program-Turkey project. Health Policy. 2015;119(1):50-56. doi:10.1016/j.healthpol.2014.11.017
 
11.
Burns DM, Anderson CM, Johnson M, Major JM, Biener L, Vaughn J, Shanks T. Cessation and Cessation Measures among Adult Daily Smokers: National and State-Specific Data. In: Population Based Smoking Cessation: Proceedings of a Conference on What Works to Influence Cessation in the General Population. Smoking and Tobacco Control Monograph No 12. Washington, DC: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute; 2000. https://cancercontrol.cancer.g.... Accessed July 5, 2019.
 
12.
Monsó E, Campbell J, Tønnesen P, Gustavsson G, Morera J. Sociodemographic predictors of success in smoking intervention. Tob Control. 2001;10(2):165-169. doi:10.1136/tc.10.2.165
 
13.
Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control. 1997;6(Suppl 2):S57-S62. doi:10.1136/tc.6.suppl_2.s57
 
14.
Lee CW, Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health. 2007;97(8):1503-1509. doi:10.2105/AJPH.2005.083527
 
15.
Kaleta D, Korytkowski P, Makowiec-Dąbrowska T, Usidame B, Bąk-Romaniszyn L, Fronczak A. Predictors of long-term smoking cessation: results from the global adult tobacco survey in Poland (2009-2010). BMC Public Health. 2012;12:1020. doi:10.1186/1471-2458-12-1020
 
16.
Osler M, Prescott E. Psychosocial, behavioural, and health determinants of successful smoking cessation: a longitudinal study of Danish adults. Tob Control. 1998;7(3):262-267. doi:10.1136/tc.7.3.262
 
17.
Caponnetto P, Polosa R. Common predictors of smoking cessation in clinical practice. Respir Med. 2008;102(8):1182-1192. doi:10.1016/j.rmed.2008.02.017
 
18.
Keizer I, Gex-Fabry M, Croquette P, Humair J, Khan AN. Tobacco craving and withdrawal symptoms in psychiatric patients during a motivational enhancement intervention based on a 26-hour smoking abstinence period. Tob Prev Cessation. 2019;5(June):1-14. doi:10.18332/tpc/109785
 
19.
Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42. PMID:16539783.
 
20.
Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000;284(20):2606-2610. doi:10.1001/jama.284.20.2606
 
21.
McClave AK, McKnight-Eily LR, Davis SP, Dube SR. Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. Am J Public Health. 2010;100(12):2464-2472. doi:10.2105/AJPH.2009.188136
 
22.
Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav. 2004;29(6):1067-1083. doi:10.1016/j.addbeh.2004.03.009
 
eISSN:2459-3087